CoChat

AAV Hybrid Serotypes: Improved Vectors for Gene Delivery

Open access
Choi, Vivian, McCarty, Douglas, Samulski, R. · 2005 · Current Gene Therapy

The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index.

Abstract

In recent years, significant efforts have been made on studying and engineering adeno-associated virus (AAV) capsid, in order to increase efficiency in targeting specific cell types that are non-permissive to wild type (wt) viruses and to improve efficacy in infecting only the cell type of interest. With our previous knowledge of the viral properties of the naturally occurring serotypes and the elucidation of their capsid structures, we can now generate capsid mutants, or hybrid serotypes, by various methods and strategies. In this review, we summarize the studies performed on AAV retargeting, and categorize the available hybrid serotypes to date, based on the type of modification: 1) transcapsidation, 2) adsorption of bi-specific antibody to capsid surface, 3) mosaic capsid, and 4) chimeric capsid. Not only these hybrid serotypes could achieve high efficiency of gene delivery to a specific targeted cell type, which can be better-tailored for a particular clinical application, but also serve as a tool for studying AAV biology such as receptor binding, trafficking and genome delivery into the nucleus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1566523054064968

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 106 references

Cited by

See all 191

Metadata

Authors
Choi, V., McCarty, D., & Samulski, R.
Affiliations
University of North Carolina at Chapel Hill (US)
Venue
Current Gene Therapy
Published
2005-06-01
Volume
5
Issue
3
Pages
299-310
ISSN
1566-5232 (ISSN-L)
OpenAlex
W2160121070
Cited by
191
References
108
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 7 · 2019: 9 · 2018: 3 · 2017: 8 · 2016: 5 · 2015: 12 · 2014: 14 · 2013: 12 · 2012: 13
FWCI
7.01
Type
journal article
Language
en
Open access
Locations
  • Current Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • National Institutes of Health (5p01gm059299-10)
  • National Heart, Lung, and Blood Institute (HL051818, P01HL051818, P01HL066973, HL 066973)
  • National Institute of General Medical Sciences (P01 GM-059299)
  • National Institute of Allergy and Infectious Diseases (R01AI048074, AI048074)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
adeno-associated virus, AAV capsid engineering, gene delivery vectors, receptor binding, viral trafficking
MeSH terms
Dependovirus, Animals, Genetic Vectors, Humans, Recombination, Genetic, Serotyping, Genetic Therapy, Gene Transfer Techniques, Capsid Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AAV Hybrid Serotypes: Improved Vectors for Gene Delivery. https://app.cochat.ai/papers/10.2174/1566523054064968
The paper
Choi, V., McCarty, D., & Samulski, R. (2005). AAV Hybrid Serotypes: Improved Vectors for Gene Delivery. Current Gene Therapy. https://doi.org/10.2174/1566523054064968

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.